Phase II trial of lurbinectedin combined with avelumab as maintenance therapy for metastatic urothelial carcinoma with stable or responding disease following platinumbased chemotherapy. Meeting Abstract

cited authors

  • Sonpavde, Guru P.; Alemany, Carlos A.; Mchayleh, Wassim; Pepe, Julie W.; Coakley, Susan; Young, Ashley; Jain, Rohit K.

Publication Date

  • February 20, 2023

webpage

published in

category

volume

  • 41